Ferran Bossacoma
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 11, 2023
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Journal: Pharmacological research
Published: September 20, 2023
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Journal: Pharmacological research
Published: March 13, 2023
Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
Journal: Pharmaceutics
Published: November 05, 2020
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease.
Journal: Journal of pediatric gastroenterology and nutrition
Published: August 11, 2020
Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection.
Journal: Ophthalmic genetics
Published: June 04, 2020
Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
Journal: International journal of molecular sciences
Published: February 19, 2020
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease.
Journal: British journal of clinical pharmacology
Published: January 24, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026